News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Novartis says study shows Gilenya benefits patients with MS

Started by riky, June 06, 2013, 09:00:28 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Novartis says study shows Gilenya benefits patients with MS

<p><a href="http://news.yahoo.com/novartis-says-study-shows-gilenya-benefits-patients-ms-054248281.html"><img src="http://l2.yimg.com/bt/api/res/1.2/ax5QW2ttqL1ceFN.EH4nng--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-05T054248Z_1_CBRE9540FVH00_RTROPTP_2_INDIA-NOVARTIS-PATENTS.JPG" width="130" height="86" alt="A Novartis logo is pictured on its headquarters building in Mumbai" align="left" title="A Novartis logo is pictured on its headquarters building in Mumbai" border="0" /></a>ZURICH (Reuters) - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease. The Basel-based pharmaceutical manufacturer is relying on new products like Gilenya to offset patent expiries of key drugs such as Diovan for high blood pressure. Switching to Gilenya from interferon increased the proportion of patients disease free after one year of treatment, Novartis said on Wednesday. (Reporting by Alice Baghdjian)</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login